Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Other Accumulated Expenses: 2017-2019

Historic Other Accumulated Expenses for Astria Therapeutics (ATXS) over the last 3 years, with Sep 2019 value amounting to $106,000.

  • Astria Therapeutics' Other Accumulated Expenses fell 69.54% to $106,000 in Q3 2019 from the same period last year, while for Sep 2019 it was $106,000, marking a year-over-year decrease of 69.54%. This contributed to the annual value of $109,000 for FY2018, which is 67.17% down from last year.
  • Per Astria Therapeutics' latest filing, its Other Accumulated Expenses stood at $106,000 for Q3 2019, which was down 39.08% from $174,000 recorded in Q2 2019.
  • Over the past 5 years, Astria Therapeutics' Other Accumulated Expenses peaked at $348,000 during Q3 2018, and registered a low of $87,000 during Q1 2019.
  • Over the past 3 years, Astria Therapeutics' median Other Accumulated Expenses value was $297,000 (recorded in 2017), while the average stood at $248,000.
  • Per our database at Business Quant, Astria Therapeutics' Other Accumulated Expenses climbed by 29.59% in 2018 and then crashed by 74.49% in 2019.
  • Over the past 3 years, Astria Therapeutics' Other Accumulated Expenses (Quarterly) stood at $332,000 in 2017, then plummeted by 67.17% to $109,000 in 2018, then plummeted by 69.54% to $106,000 in 2019.
  • Its Other Accumulated Expenses stands at $106,000 for Q3 2019, versus $174,000 for Q2 2019 and $87,000 for Q1 2019.